Epigenictx
Founded 2021 · 17 employees on LinkedIn · 2 known investors
Epigenic Therapeutics develops epigenetic medicines using an Epigenetic Modulator platform that combines nuclease-inactivated dead Cas proteins with epi-enzymes to control gene expression without cutting or altering DNA. The company applies this technology to treat hard-to-treat diseases, including chronic Hepatitis B, and delivers its therapies via proprietary LNP formulations.
Founders & leadership
CY
Chloe YouChief Medical Officer
KS
Kelly ShiChief Financial Officer
Investors · 2
Frequently asked questions
- What does Epigenictx do?
- Epigenic Therapeutics develops epigenetic medicines using an Epigenetic Modulator platform that combines nuclease-inactivated dead Cas proteins with epi-enzymes to control gene expression without cutting or altering DNA. The company applies this technology to treat hard-to-treat diseases, including chronic Hepatitis B, and delivers its therapies via proprietary LNP formulations.
- Who are Epigenictx's investors?
- Epigenictx's investors include OrbiMed, Qiming Venture Partners.